Grant A. Yonehiro's most recent trade in Bolt Biotherapeutics Inc was a trade of 350,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bolt Biotherapeutics Inc | Grant A. Yonehiro | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 350,000 | 350,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | Grant A. Yonehiro | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2024 | 155,000 | 155,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | Grant A. Yonehiro | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 235,000 | 235,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | Grant Yonehiro A. | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 0.78 per share. | 31 Dec 2023 | 2,500 | 8,918 | - | 0.8 | 1,955 | Common Stock |
| Bolt Biotherapeutics Inc | Grant A. Yonehiro | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 228,000 | 228,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | Grant A. Yonehiro | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.64 per share. | 31 Dec 2022 | 2,500 | 3,918 | - | 1.6 | 4,101 | Common Stock |
| Bolt Biotherapeutics Inc | Grant A. Yonehiro | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 31 Dec 2022 | 2,500 | 6,418 | - | 1.2 | 2,954 | Common Stock |
| Bolt Biotherapeutics Inc | Grant A. Yonehiro | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 190,000 | 190,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | Grant A. Yonehiro | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) |